Valuation: Evogene Ltd.

Market Cap 6.32M 1.93B 5.62M 5.24M 4.78M 9.01M 609M 9.1M 63.52M 24.62M 311M 23.74M 23.23M 998M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6.32M 1.93B 5.62M 5.24M 4.78M 9.01M 609M 9.1M 63.52M 24.62M 311M 23.74M 23.23M 998M EV / Sales 2026 *
4.4x
EV / Sales 2027 * 2.43x
Free-Float
72.14%
Yield 2026 *
-
Yield 2027 * -
1 day-3.59%
1 week-9.46%
Current month-3.59%
1 month-24.09%
3 months-6.08%
6 months-50.58%
Current year-58.92%
1 week 113.3
Extreme 113.3
164.6
1 month 113.3
Extreme 113.3
173.1
Current year 113.3
Extreme 113.3
410
1 year 113.3
Extreme 113.3
478.7
3 years 113.3
Extreme 113.3
3,700
5 years 113.3
Extreme 113.3
9,289
10 years 113.3
Extreme 113.3
33,500
Manager TitleAgeSince
Chief Executive Officer 60 2004-11-30
Corporate Officer/Principal - -
Corporate Officer/Principal - 2021-12-31
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 2010-06-02
Chairman 60 2021-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Free

Chairman

10,000 0.0754%
9/4/26 Other

Director

2,500 0.0189%
9/4/26 Free

Director

2,500 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
-3.59%-9.46%-68.77%-94.64% 6.38M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.56%-1.48%+42.07%+98.79% 39.05B
Weighted average by Cap. +0.12%-0.84%+58.76%+129.90%

Financials

2026 *2027 *
Net sales 1.44M 438M 1.28M 1.19M 1.08M 2.05M 138M 2.07M 14.42M 5.59M 70.52M 5.39M 5.27M 227M 2.6M 794M 2.31M 2.15M 1.96M 3.7M 250M 3.74M 26.11M 10.12M 128M 9.76M 9.55M 410M
Net income -12.17M -3.72B -10.82M -10.08M -9.19M -17.34M -1.17B -17.5M -122M -47.36M -598M -45.68M -44.69M -1.92B -10.2M -3.11B -9.07M -8.45M -7.7M -14.53M -982M -14.67M -102M -39.7M -501M -38.29M -37.46M -1.61B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
26-10-01 ILA 123.50 -3.59% 93,252
26-09-30 ILA 128.10 +13.06% 580,165
26-09-29 ILA 113.30 -17.72% 311,774
26-09-28 ILA 137.70 +0.95% 25,699

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock